SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20047126
Source:
http://linkedlifedata.com/resource/pubmed/id/20047126
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0048808
,
umls-concept:C0205179
,
umls-concept:C0246415
,
umls-concept:C0278502
,
umls-concept:C0282460
,
umls-concept:C1521750
pubmed:issue
4
pubmed:dateCreated
2010-1-4
pubmed:abstractText
The aim of this study was to establish the efficacy and safety of doxifluridine and docetaxel for patients with advanced or recurrent gastric cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100886238
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Floxuridine
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
,
http://linkedlifedata.com/resource/pubmed/chemical/doxifluridine
pubmed:status
MEDLINE
pubmed:issn
1436-3291
pubmed:author
pubmed-author:HatayaKiyoshiK
,
pubmed-author:KimuraMasayukiM
,
pubmed-author:KobayashiOsamuO
,
pubmed-author:KoizumiWasaburoW
,
pubmed-author:NabeshimaKazuhitoK
,
pubmed-author:SatoAtsushiA
,
pubmed-author:ShimadaKenK
,
pubmed-author:TakahashiMakotoM
,
pubmed-author:TsuburayaAkiraA
,
pubmed-author:YoshikawaTakakiT
,
pubmed-author:YoshizawaYasuoY
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
212-8
pubmed:meshHeading
pubmed-meshheading:20047126-Administration, Oral
,
pubmed-meshheading:20047126-Adult
,
pubmed-meshheading:20047126-Aged
,
pubmed-meshheading:20047126-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:20047126-Disease-Free Survival
,
pubmed-meshheading:20047126-Female
,
pubmed-meshheading:20047126-Floxuridine
,
pubmed-meshheading:20047126-Humans
,
pubmed-meshheading:20047126-Infusions, Intravenous
,
pubmed-meshheading:20047126-Male
,
pubmed-meshheading:20047126-Middle Aged
,
pubmed-meshheading:20047126-Neoplasm Recurrence, Local
,
pubmed-meshheading:20047126-Stomach Neoplasms
,
pubmed-meshheading:20047126-Survival Rate
,
pubmed-meshheading:20047126-Taxoids
,
pubmed-meshheading:20047126-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer.
pubmed:affiliation
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama 241-0815, Japan.
pubmed:publicationType
Journal Article
,
Clinical Trial, Phase II